Thus, it appears that sarpogrelate produces antidiabetic insulin-like effects to promote glucose utilization, reduce lipid levels and attenuate diabetes-induced defects in heart function both by acting on 5-HT2A receptors and through the release of insulin from the pancreas. This evidence concerns the gene INS and diabetes mellitus.